Alix Coste

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


83 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2004 | 2001 | 2000 |
2024
 
Exploration of novel mechanisms of azole resistance in Candida auris.
Li J., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/12/05. Antimicrobial agents and chemotherapy, 68 (12) pp. e0126524. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_833F84ADFDA1]
 
Ume6-dependent pathways of morphogenesis and biofilm formation in Candida auris.
Louvet M., Li J., Brandalise D., Bachmann D., Sala de Oyanguren F., Labes D., Jacquier N., Genoud C., Mucciolo A., Coste A.T. et al., 2024/11/05. Microbiology spectrum, 12 (11) pp. e0153124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21541699EAF6]
Syphilis in pregnant women and congenital syphilis from 2012 to 2021 in Switzerland: a multicentre, retrospective study.
Alberto C., Wagner N., Fougère Y., Meyer Sauteur P.M., Scherler G., Aebbi-Popp K., Baumann M., Schöbi N., Catho G., Emonet S. et al., 2024/11/01. Swiss medical weekly, 154 p. 3678. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_20622B162454]
 
A reporter virus particle seroneutralization assay for tick-borne encephalitis virus overcomes ELISA limitations.
Ackermann-Gäumann R., Dentand A., Lienhard R., Saeed M., Speiser D.E., MacDonald M.R., Coste A.T., Cagno V., 2024/08. Journal of medical virology, 96 (8) pp. e29843. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60C8B876F1D2]
 
Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case-control study.
Alberto C., Lambeng N., Deffert C., Breville G., Gayet-Ageron A., Lalive P., Calmy A., Coste A., Papadimitriou-Olivgeris M., Braun D. et al., 2024/02/19. Sexually transmitted infections, 100 (2) pp. 63-69. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F0E982EA4EF]
Upc2-mediated mechanisms of azole resistance in Candida auris.
Li J., Aubry L., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/02/06. Microbiology spectrum, 12 (2) pp. e0352623. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D81064ADA623]
 
A reporter virus particle seroneutralization assay for tick-borne encephalitis virus overcomes ELISA limitations
Ackermann-Gäumann Rahel, Dentand Alexis, Lienhard Reto, Saeed Mohsan, MacDonald Margaret R., Coste Alix T, Cagno Valeria, 2024/01/23..
[DOI][serval:BIB_39350768BF84]
2023
IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.
Coste A.T., Egli A., Schrenzel J., Nickel B., Zbinden A., Lienhard R., Dumoulin A., Risch M., Greub G., Coordinated Clinical Commission of Microbiology (CCCM), 2023/09/11. Diagnostics, 13 (18). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DA76705655D]
 
Changes in the fungal nomenclature: Why and how to manage?
Hennequin C., Coste A., Imbert C., 2023/05. Journal de mycologie medicale, 33 (2) p. 101404. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2F90B751F38]
 
Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
Li J., Coste A.T., Liechti M., Bachmann D., Sanglard D., Lamoth F., 2023/05/01. Antimicrobial agents and chemotherapy, 65 (5) pp. e02663-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82EB6D2906CE]
Échinococcose alvéolaire : prise en charge en 2023 [2023 update on alveolar echinococcosis]
Gauthiez E., Uldry E., Coste A.T., Prior J., Cavassini M., Munting A., 2023/04/12. Revue medicale suisse, 19 (822) pp. 708-712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3120FE82293D]
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24963B96DCC0]
 
Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains.
Cuénod A., Aerni M., Bagutti C., Bayraktar B., Boz E.S., Carneiro C.B., Casanova C., Coste A.T., Damborg P., van Dam D.W. et al., 2023/02. Clinical microbiology and infection, 29 (2) pp. 190-199. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0CFEBB3DD03]
2022
The importance of antimicrobial resistance in medical mycology.
Gow NAR, Johnson C., Berman J., Coste A.T., Cuomo C.A., Perlin D.S., Bicanic T., Harrison T.S., Wiederhold N., Bromley M. et al., 2022/09/12. Nature communications, 13 (1) p. 5352. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC8486DC2F86]
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
Papadimitriou-Olivgeris M., Battistolo J., Poissy J., Coste A., Bochud P.Y., Calandra T., Senn L., Lamoth F., 2022/08. Open forum infectious diseases, 9 (8) pp. ofac383. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16BC39E44CF1]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
 
Overview about Candida auris: What's up 12 years after its first description?
Desoubeaux G., Coste A.T., Imbert C., Hennequin C., 2022/05. Journal de mycologie medicale, 32 (2) p. 101248. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8590DF26BAD7]
 
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2022/04/19. Antimicrobial agents and chemotherapy, 66 (4) pp. e0006722. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89B82C9DD605]
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
Pellaton N., Sanglard D., Lamoth F., Coste A.T., 2022. Frontiers in cellular and infection microbiology, 12 p. 859439. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC99145B5F54]
2021
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2021/12/22. Microbiology spectrum, 9 (3) pp. e0139521. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A88593023DD0]
 
Evaluation of sixteen ELISA SARS-CoV-2 serological tests.
Jacot D., Moraz M., Coste A.T., Aubry C., Sacks J.A., Greub G., Croxatto A., 2021/09. Journal of clinical virology, 142 p. 104931. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00982AEB2445]
Performance evaluation of the Becton Dickinson Kiestra™ IdentifA/SusceptA.
Jacot D., Sarton-Lohéac G., Coste A.T., Bertelli C., Greub G., Prod'hom G., Croxatto A., 2021/08. Clinical microbiology and infection, 27 (8) pp. 1167.e9-1167.e17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_85C11972FFBD]
 
Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.
Aruanno M., Gozel S., Mouyna I., Parker J.E., Bachmann D., Flamant P., Coste A.T., Sanglard D., Lamoth F., 2021/07/14. Medical mycology, 59 (8) pp. 763-772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B19CC367C75B]
Self-testing for SARS-CoV-2: importance of lay communication.
Coste A.T., Egli A., Greub G., 2021/05/24. Swiss medical weekly, 151 pp. w20526. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A3FF3275F622]
 
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.
Glampedakis E., Cassaing S., Fekkar A., Dannaoui E., Bougnoux M.E., Bretagne S., Neofytos D., Schreiber P.W., Hennequin C., Morio F. et al., 2021/04/26. Clinical infectious diseases, 72 (8) pp. 1379-1385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_102BDCBA5418]
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
Fenwick C., Croxatto A., Coste A.T., Pojer F., André C., Pellaton C., Farina A., Campos J., Hacker D., Lau K. et al., 2021/01/13. Journal of virology, 95 (3) pp. e01828-20. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_95BA21CCB9C1]
 
Comparison of SARS-CoV-2 serological tests with different antigen targets.
Coste A.T., Jaton K., Papadimitriou-Olivgeris M., Greub G., Croxatto A., 2021/01. Journal of clinical virology, 134 p. 104690. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E2447F373497]
Function Analysis of MBF1, a Factor Involved in the Response to Amino Acid Starvation and Virulence in Candida albicans.
Amorim-Vaz S., Coste A.T., Tran VDT, Pagni M., Sanglard D., 2021. Frontiers in fungal biology, 2 p. 658899. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_854842775929]
2020
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.
Coste A.T., Kritikos A., Li J., Khanna N., Goldenberger D., Garzoni C., Zehnder C., Boggian K., Neofytos D., Riat A. et al., 2020/10. Infection, 48 (5) pp. 761-766. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EF468599D088]
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results.
Caruana G., Croxatto A., Coste A.T., Opota O., Lamoth F., Jaton K., Greub G., 2020/09. Clinical microbiology and infection, 26 (9) pp. 1178-1182. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EB349E4D572A]
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
Stavropoulou E., Coste A.T., Beigelman-Aubry C., Letovanec I., Spertini O., Lovis A., Krueger T., Burger R., Bochud P.Y., Lamoth F., 2020/07/22. BMC infectious diseases, 20 (1) p. 527. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8DBE542AD411]
Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization.
Perret T., Kritikos A., Hauser P.M., Guiver M., Coste A.T., Jaton K., Lamoth F., 2020/05. Journal of medical microbiology, 69 (5) pp. 705-711. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BFDF364602B9]
Evaluation of the BD Phoenix™ CPO Detect Test for the detection of carbapenemase producers.
Croxatto A., Coste A.T., Pillonel T., Bertelli C., Greub G., Prod'hom G., 2020/05. Clinical microbiology and infection, 26 (5) pp. 644.e9-644.e15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10B221FFC8D5]
 
2020: A new year for Medical Mycology and medical mycologists.
Coste A., Imbert C., Hennequin C., 2020/04. Journal de mycologie medicale, 30 (1) p. 100937. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DADCB8903714]
 
Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
Sitterlé E., Coste A.T., Obadia T., Maufrais C., Chauvel M., Sertour N., Sanglard D., Puel A., D'Enfert C., Bougnoux M.E., 2020/04/01. The Journal of antimicrobial chemotherapy, 75 (4) pp. 835-848. Peer-reviewed.
[DOI][Pmid][serval:BIB_DE0060C0C427]
Immunosuppressed gardener pricked by roses grows Legionella longbeachae.
Desgranges F., Coste A.T., Wernly D., Dufour J., Opota O., Meylan S., 2020/02/22. Lancet, 395 (10224) p. 604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7D8B58E9D82E]
2019
Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis.
Tran VDT, Moretti S., Coste A.T., Amorim-Vaz S., Sanglard D., Pagni M., 2019/07/01. Bioinformatics, 35 (13) pp. 2258-2266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3E96F1A1B541]
 
Candida auris, an emerging and disturbing yeast
Coste A.T., Imbert C., Hennequin C., 2019/06. Journal de Mycologie Médicale, 29 (2) pp. 105-106.
[DOI][WoS][Pmid][serval:BIB_FB7F4EE50B7A]
Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays.
Delavy M., Dos Santos A.R., Heiman C.M., Coste A.T., 2019. Frontiers in cellular and infection microbiology, 9 p. 19. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E4799E9694B]
Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Delavy M., Cerutti L., Croxatto A., Prod'hom G., Sanglard D., Greub G., Coste A.T., 2019. Frontiers in microbiology, 10 p. 3000. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8EF5D09A167E]
Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018.
Rodríguez-Sánchez B., Cercenado E., Coste A.T., Greub G., 2019/01. Euro surveillance, 24 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D38550346899]
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.
Chaabane F., Graf A., Jequier L., Coste A.T., 2019. Frontiers in microbiology, 10 p. 2788. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_12AA1B08BAC1]
2018
 
Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
Glampedakis E., Coste A.T., Aruanno M., Bachmann D., Delarze E., Erard V., Lamoth F., 2018/12. Antimicrobial agents and chemotherapy, 62 (12). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96BD38D42E6D]
 
One fungus, several microbes
Imbert C., Hennequin C., Coste A., 2018/09. Journal de Mycologie Médicale, 28 (3) p. 413.
[DOI][WoS][Pmid][serval:BIB_2392778FB3A5]
 
Editorial
Coste A., Imbert C., Hennequin C., 2018/06. Journal de Mycologie Médicale, 28 (2) p. 235.
[DOI][WoS][Pmid][serval:BIB_6CF624F92C3F]
 
Azole resistance in a <i>Candida albicans</i> mutant lacking the ABC transporter <i>CDR6/ROA1</i> depends on TOR signaling.
Khandelwal N.K., Chauhan N., Sarkar P., Esquivel B.D., Coccetti P., Singh A., Coste A.T., Gupta M., Sanglard D., White T.C. et al., 2018/01/12. The Journal of biological chemistry, 293 (2) pp. 412-432. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_383820A83AF7]
 
A standardized toolkit for genetic engineering of CTG clade yeasts.
Defosse T.A., Courdavault V., Coste A.T., Clastre M., de Bernonville T.D., Godon C., Vandeputte P., Lanoue A., Touzé A., Linder T. et al., 2018/01. Journal of microbiological methods, 144 pp. 152-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_86F8089ABB9C]
First case of Candida auris in Switzerland: discussion about preventive strategies.
Riat A., Neofytos D., Coste A., Harbarth S., Bizzini A., Grandbastien B., Pugin J., Lamoth F., 2018. Swiss medical weekly, 148 pp. w14622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C56C1C51FBC4]
2017
Azole Resistance in <i>Aspergillus fumigatus</i>: A Consequence of Antifungal Use in Agriculture?
Berger S., El Chazli Y., Babu A.F., Coste A.T., 2017. Frontiers in microbiology, 8 p. 1024. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1A23EADC0745]
Red-Shifted Firefly Luciferase Optimized for Candida albicans In vivo Bioluminescence Imaging.
Dorsaz S., Coste A.T., Sanglard D., 2017. Frontiers in microbiology, 8 p. 1478. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC850AC0034E]
Unexpected Transcripts in Tn7 orf19.2646 C. albicans Mutant Lead to Low Fungal Burden Phenotype In vivo.
Pierrehumbert A., Ischer F., Coste A.T., 2017. Frontiers in microbiology, 8 p. 873. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_57C56BED65B4]
2016
Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence.
Khandelwal N.K., Kaemmer P., Förster T.M., Singh A., Coste A.T., Andes D.R., Hube B., Sanglard D., Chauhan N., Kaur R. et al., 2016/06/01. The Biochemical journal, 473 (11) pp. 1537-1552. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A79907FCE04B]
 
Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.
Meneau I., Coste A.T., Sanglard D., 2016/03/01. Medical mycology, 54 (6) pp. 616-627. Peer-reviewed.
[DOI][Pmid][serval:BIB_BDD96692A0AD]
2015
 
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D., Coste A.T., 2015. Antimicrobial Agents and Chemotherapy, 60 (1) pp. 229-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B9296518A78]
 
Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.
Delarze E., Ischer F., Sanglard D., Coste A.T., 2015. Virulence, 6 (7) pp. 684-693. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C6B9350CE74B]
 
Animal Models to Study Fungal Virulence and Antifungal Drugs
Coste Alix T., Amorim-Vaz Sara, 2015. pp. 289-316 dans Coste Alix T., Vandeputte Patrick (eds.) Antifungals: From Genomics to Resistance and the Development of Novel Agents chap. 13, Caister Academic Press.
[DOI][serval:BIB_667853F9D323]
 
Antifungals: From Genomics to Resistance and the Development of Novel Agents
Coste Alix, Vandeputte Patrick (eds.), 2015., Caister Academic Press.
[DOI][serval:BIB_C4B122DBC3F7]
Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models.
Amorim-Vaz S., Delarze E., Ischer F., Sanglard D., Coste A.T., 2015. Frontiers in Microbiology, 6 p. 367. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_777D65B6ECFD]
RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans.
Amorim-Vaz S., Tran Vdu T, Pradervand S., Pagni M., Coste A.T., Sanglard D., 2015. Mbio, 6 (5) pp. e00942-e00915. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66ED2062C4C0]
2014
 
Distinct Roles of Candida albicans Drug Resistance Transcription Factors TAC1, MRR1, and UPC2 in Virulence.
Lohberger A., Coste A.T., Sanglard D., 2014. Eukaryotic Cell, 13 (1) pp. 127-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2F8AD0FFBDF]
2013
 
Molecular mechanisms of drug resistance in clinical Candida species isolated from tunisian hospitals.
Eddouzi J., Parker J.E., Vale-Silva L.A., Coste A., Ischer F., Kelly S., Manai M., Sanglard D., 2013. Antimicrobial Agents and Chemotherapy, 57 (7) pp. 3182-3193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E944B6CFEA1]
2012
Antifungal resistance and new strategies to control fungal infections.
Vandeputte P., Ferrari S., Coste A.T., 2012. International Journal of Microbiology, 2012 (713687) pp. 1-26. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_24739707241E]
 
Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Vale-Silva L.A., Coste A.T., Ischer F., Parker J.E., Kelly S.L., Pinto E., Sanglard D., 2012. Antimicrobial Agents and Chemotherapy, 56 (4) pp. 1960-1968.
[DOI][WoS][Pmid][serval:BIB_D6282653AFC6]
 
Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans.
Vandeputte P., Pradervand S., Ischer F., Coste A.T., Ferrari S., Harshman K., Sanglard D., 2012. Eukaryotic Cell, 11 (7) pp. 916-931.
[DOI][WoS][Pmid][serval:BIB_76A13529CFF2]
Species-Specific Recognition of Aspergillus fumigatus by Toll-like Receptor 1 and Toll-like Receptor 6.
Rubino I., Coste A., Le Roy D., Roger T., Jaton K., Boeckh M., Monod M., Latgé J.P., Calandra T., Bochud P.Y., 2012. Journal of Infectious Diseases, 205 (6) pp. 944-954. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5B3E6BB03173]
2011
Doxorubicin induces drug efflux pumps in Candida albicans.
Kofla G., Turner V., Schulz B., Storch U., Froelich D., Rognon B., Coste A.T., Sanglard D., Ruhnke M., 2011. Medical Mycology, 49 (2) pp. 132-142.
[URN][DOI][WoS][Pmid][serval:BIB_E9854960CDC4]
In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization.
Vandeputte P., Ischer F., Sanglard D., Coste A.T., 2011. Plos One, 6 (10) pp. e26962.
[URN][DOI][WoS][Pmid][serval:BIB_348842892409]
2010
 
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
MacCallum D.M., Coste A., Ischer F., Jacobsen M.D., Odds F.C., Sanglard D., 2010. Antimicrobial Agents and Chemotherapy, 54 (4) pp. 1476-1483.
[DOI][WoS][Pmid][serval:BIB_526CEFFDEEC7]
2009
 
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
Sanglard D., Coste A., Ferrari S., 2009. FEMS Yeast Research, 9 (7) pp. 1029-1050.
[DOI][WoS][Pmid][serval:BIB_BFDED9BC0876]
 
Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.
Coste A.T., Crittin J., Bauser C., Rohde B., Sanglard D., 2009. Eukaryotic Cell, 8 (8) pp. 1250-1267.
[DOI][WoS][Pmid][serval:BIB_EB86556E7C09]
2008
 
Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste A.T., Ramsdale M., Ischer F., Sanglard D., 2008. Microbiology, 154 (Pt 5) pp. 1491-1501. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C94D6350A19]
 
Modulation of chemokine gene expression by Shiga-toxin producing Escherichia coli belonging to various origins and serotypes.
Gobert A.P., Coste A., Guzman C.A., Vareille M., Hindré T., de Sablet T., Girardeau J.P., Martin C., 2008. Microbes and Infection / Institut Pasteur, 10 (2) pp. 159-165. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6588879FBB91]
2007
 
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates
Coste A., Selmecki A., Forche A., Diogo D., Bougnoux M. E., d'Enfert C., Berman J., Sanglard D., 2007/10. Eukaryotic Cell, 6 (10) pp. 1889-904.
[DOI][WoS][Pmid][serval:BIB_BF72C7DB9CA1]
2006
 
Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance
Rognon B., Kozovska Z., Coste A. T., Pardini G., Sanglard D., 2006/12. Microbiology, 152 (Pt 12) pp. 3701-22.
[DOI][WoS][Pmid][serval:BIB_A884E875DA4E]
 
The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans.
Pardini G., De Groot P.W., Coste A.T., Karababa M., Klis F.M., de Koster C.G., Sanglard D., 2006/12. Journal of Biological Chemistry, 281 (52) pp. 40399-40411. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A411FA969957]
 
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans
Coste A., Turner V., Ischer F., Morschhauser J., Forche A., Selmecki A., Berman J., Bille J., Sanglard D., 2006/04. Genetics, 172 (4) pp. 2139-56.
[DOI][WoS][Pmid][serval:BIB_D18DEFD4A327]
 
CRZ1, a target of the calcineurin pathway in Candida albicans
Karababa M., Valentino E., Pardini G., Coste A. T., Bille J., Sanglard D., 2006/03. Molecular Microbiology, 59 (5) pp. 1429-51.
[DOI][WoS][Pmid][serval:BIB_EA90689D963D]
2004
 
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2
Coste A. T., Karababa M., Ischer F., Bille J., Sanglard D., 2004/12. Eukaryotic Cell, 3 (6) pp. 1639-52.
[DOI][WoS][Pmid][serval:BIB_D5184959356F]
 
Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters
Karababa M., Coste A. T., Rognon B., Bille J., Sanglard D., 2004/08. Antimicrobial Agents and Chemotherapy, 48 (8) pp. 3064-79.
[DOI][WoS][Pmid][serval:BIB_076596EEE6FB]
2001
 
Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring
Coste A., Cohen J., Reinhardt M., Kraehenbuhl J. P., Sirard J. C., 2001/07. Vaccine, 19 (30) pp. 4167-74.
[DOI][WoS][Pmid][serval:BIB_2E105AA6258A]
 
First evidence of lysogeny in Propionibacterium freudenreichii subsp. shermanii.
Hervé C., Coste A., Rouault A., Fraslin J.M., Gautier M., 2001. Applied and Environmental Microbiology, 67 (1) pp. 231-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E52747C8F033]
 
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells.
Sierro F., Dubois B., Coste A., Kaiserlian D., Kraehenbuhl J.P., Sirard J.C., 2001. Proceedings of the National Academy of Sciences of the United States of America, 98 (24) pp. 13722-13727. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20742]
2000
 
Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea.
Coste A., Sirard J.C., Johansen K., Cohen J., Kraehenbuhl J.P., 2000. Journal of virology, 74 (19) pp. 8966-71. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D1D101F72124]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University